Biosimilars for Cancer Treatment: A Promising Approach

Shvetank Bhatta; Harish Durejaa; Samir Gunvantbhai Patel; Archita Samir Patel; Kamal Dua

doi:10.1007/978-981-97-3001-8

Biosimilars for Cancer Treatment: A Promising Approach

Shvetank Bhatta
, Harish Durejaa
, Samir Gunvantbhai Patel
, Archita Samir Patel
, Kamal Dua

MIT World Peace University
Maharshi Dayanand University
Charotar University of Science Technology
Charotar University of Science and Technology
University of Technology Sydney

Research output: Book/Report › Book › peer-review

2 Scopus citations

Abstract

The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.

Original language	English
Publisher	Springer Nature
Number of pages	309
ISBN (Electronic)	9789819730018
ISBN (Print)	9789819730001
DOIs	https://doi.org/10.1007/978-981-97-3001-8
State	Published - 1 Jan 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biosimilar Therapy
Breast Cancer Therapeutics
Cervical Cancer Treatment with Biosimilars
Hepatocellular Carcinoma and Biosimilars
Immunobiology of Cancer in
Management with biosimilars
Prostate Cancer
Rituximab Biosimilar Drug
Trastuzumab Biosimilar Drug

Access to Document

10.1007/978-981-97-3001-8

Cite this

@book{b56a776728be48d0b73708492dde9a4b,

title = "Biosimilars for Cancer Treatment: A Promising Approach",

abstract = "The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.",

keywords = "Biosimilar Therapy, Breast Cancer Therapeutics, Cervical Cancer Treatment with Biosimilars, Hepatocellular Carcinoma and Biosimilars, Immunobiology of Cancer in, Management with biosimilars, Prostate Cancer, Rituximab Biosimilar Drug, Trastuzumab Biosimilar Drug",

author = "Shvetank Bhatta and Harish Durejaa and Patel, \{Samir Gunvantbhai\} and Patel, \{Archita Samir\} and Kamal Dua",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-981-97-3001-8",

language = "English",

isbn = "9789819730001",

publisher = "Springer Nature",

}

TY - BOOK

T1 - Biosimilars for Cancer Treatment

T2 - A Promising Approach

AU - Bhatta, Shvetank

AU - Durejaa, Harish

AU - Patel, Samir Gunvantbhai

AU - Patel, Archita Samir

AU - Dua, Kamal

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.

AB - The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.

KW - Biosimilar Therapy

KW - Breast Cancer Therapeutics

KW - Cervical Cancer Treatment with Biosimilars

KW - Hepatocellular Carcinoma and Biosimilars

KW - Immunobiology of Cancer in

KW - Management with biosimilars

KW - Prostate Cancer

KW - Rituximab Biosimilar Drug

KW - Trastuzumab Biosimilar Drug

UR - https://www.scopus.com/pages/publications/85211887146

U2 - 10.1007/978-981-97-3001-8

DO - 10.1007/978-981-97-3001-8

M3 - Book

AN - SCOPUS:85211887146

SN - 9789819730001

BT - Biosimilars for Cancer Treatment

PB - Springer Nature

ER -

Biosimilars for Cancer Treatment: A Promising Approach

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this